💡 What You Need to Know Right Away
- NAD+ is fundamental for energy metabolism, cell signaling, and mitochondrial function, with three primary precursors (NR, NMN, NRH) showing therapeutic potential[Evidence: A][6]
- Oral nicotinamide riboside (NR) supplementation at 500 mg twice daily increased NAD+ levels in neuronal extracellular vesicles and lowered neurodegenerative biomarkers in healthy older adults[Evidence: B][7]
- A meta-analysis of 12 randomized controlled trials with 513 participants confirmed that NMN supplementation elevates blood NAD+ levels[Evidence: A][2]
- NADH supplementation demonstrates a favorable safety profile with low incidence of adverse effects across clinical studies[Evidence: A][1]
NAD+ testing has emerged as a tool in longevity medicine, helping individuals understand their cellular energy status and track the effectiveness of interventions designed to boost this critical coenzyme.
NAD+ (nicotinamide adenine dinucleotide) plays essential roles in metabolism, energy production, DNA repair, mitophagy, and autophagy.[Evidence: D][5] Research shows that NAD+ levels decline with aging, affecting all hallmarks of the aging process.[Evidence: D][5]
This guide examines what current research reveals about NAD+ testing, the methodologies used to measure NAD+ levels, safety considerations for NAD+ precursor supplementation, and what the evidence actually supports. Multiple human clinical trials investigating NAD+ augmentation are currently underway.[Evidence: D][5]
❓ Quick Answers
What does NAD+ testing measure?
NAD+ testing measures levels of nicotinamide adenine dinucleotide and related metabolites (the "NADome") in biological samples. Laboratory methods like LC-MS/MS can quantify NAD+ metabolites in blood, plasma, cells, platelets, cerebrospinal fluid, and urine samples.[Evidence: D][4] These metabolites influence cellular metabolism, inflammation, and oxidative stress.[Evidence: D][4]
How do you test NAD+ levels?
NAD+ levels are tested using analytical chemistry methods, with liquid chromatography-mass spectrometry (LC-MS/MS) being a validated approach for NAD+ metabolite quantification.[Evidence: D][4] Testing involves collecting biological samples (blood, plasma, or cells), which are then processed in specialized laboratories. The methodology addresses sample instability challenges inherent in NAD+ measurement.[Evidence: D][4]
What is the role of NAD+ in the body?
NAD+ serves as a critical coenzyme in glycolysis and oxidative phosphorylation, the processes that generate cellular energy.[Evidence: D][10] NAD+ and NADH maintain cellular redox balance through electron transport.[Evidence: D][10] Beyond energy production, NAD+ is involved in DNA repair, mitophagy, autophagy, and influences inflammation and neuronal signaling.[Evidence: D][5]
Can NAD+ precursor supplementation raise NAD+ levels?
Yes, research demonstrates that NAD+ precursor supplementation can elevate NAD+ levels. A meta-analysis of 12 randomized controlled trials (513 participants) found that NMN supplementation elevated blood NAD+ levels.[Evidence: A][2] An RCT also showed oral nicotinamide riboside at 500 mg twice daily for 6 weeks increased NAD+ in neuronal extracellular vesicles.[Evidence: B][7]
When should someone consider testing NAD+ levels?
Testing NAD+ levels may be considered by individuals who want to track the effectiveness of NAD+ precursor supplementation, those interested in biological aging biomarkers, or people experiencing symptoms potentially related to cellular energy decline. NAD+ declines with aging, affecting all hallmarks of the aging process.[Evidence: D][5] Testing can establish a baseline before starting interventions and monitor response over time.
What NAD+ precursors are used to boost levels?
Three primary NAD+ precursors have been identified: nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and nicotinamide riboside hydride (NRH).[Evidence: A][6] Animal studies show NAD+ repletion through these precursors extends healthspan and lifespan, with therapeutic potential for aging, metabolic, and neurodegenerative diseases.[Evidence: A][6]
Is NAD+ testing validated by research?
LC-MS/MS methodology for NAD+ metabolite quantification has been described in peer-reviewed literature as applicable to various biological samples.[Evidence: D][4] However, standardized clinical reference ranges are still being established, and the clinical utility of NAD+ testing in routine practice continues to be evaluated in ongoing research.[Evidence: D][5]
🔬 How Does NAD+ Testing Work?
Understanding NAD+ testing requires grasping what this molecule does in your body. Think of NAD+ as the molecular currency your cells use to pay for energy transactions—without sufficient NAD+, cellular processes begin to run on a deficit, much like a bank account running low on funds.
NAD+ is fundamental for energy metabolism, cell signaling, and mitochondrial homeostasis.[Evidence: A][6] It functions as a coenzyme in glycolysis and oxidative phosphorylation, the core pathways that generate ATP (cellular energy).[Evidence: D][10] NAD+ and its reduced form NADH maintain cellular redox balance by shuttling electrons during metabolic reactions.[Evidence: D][10]
The Testing Methodology
NAD+ testing uses sophisticated analytical chemistry to measure this critical coenzyme. The LC-MS/MS (liquid chromatography-mass spectrometry) method provides quantification of NAD+ metabolites—collectively called the "NADome."[Evidence: D][4]
This testing methodology is applicable to multiple biological sample types, including blood, plasma, cells, platelets, cerebrospinal fluid, and urine.[Evidence: D][4] Like capturing a snapshot of your financial portfolio, NAD+ testing provides a picture of your cellular energy reserves at a specific moment.
A key challenge in NAD+ measurement is sample instability—NAD+ can degrade quickly after sample collection. Modern testing methods have been designed to address these stability challenges.[Evidence: D][4]
Why NAD+ Levels Matter
Research demonstrates that NAD+ plays essential roles beyond energy production. It is involved in DNA repair, mitophagy (clearing damaged mitochondria), and autophagy (cellular cleanup).[Evidence: D][5] NAD+ also influences inflammation and neuronal signaling pathways.[Evidence: D][5]
NAD+ declines with aging, affecting all hallmarks of the aging process.[Evidence: D][5] This age-related decline has made NAD+ a target for longevity research, with preclinical evidence supporting NAD+ precursors for conditions like Alzheimer's and Parkinson's disease.[Evidence: D][5]
A systematic review examining 147 studies (113 preclinical and 34 clinical) found that NAD+ precursors showed favorable outcomes in age-related disorders.[Evidence: D][8]
📊 NAD+ Precursor Dosages Used in Research
While NAD+ testing itself does not involve dosage decisions, understanding the supplementation doses used in research helps contextualize what NAD+ testing monitors. The following table summarizes dosages from peer-reviewed clinical studies.
| Precursor/Purpose | Dosage | Duration | Population | Evidence |
|---|---|---|---|---|
| NMN for glucose/lipid metabolism | 250-1000 mg daily | 12 weeks | Adults | [A][2] |
| NMN for physical performance | 150-1200 mg daily | 9-12 weeks | Adults, average age 58 | [A][3] |
| NR for neuronal NAD+ elevation | 500 mg twice daily (1000 mg/day total) | 6 weeks | Healthy older adults | [B][7] |
| Nicotinamide safety threshold | <1500 mg daily | Ongoing | General population | [D][9] |
Key Observations from Research
A systematic review of 10 RCTs involving 437 patients (average age 58) evaluated NMN at doses of 150-1200 mg daily for 9-12 weeks. The review found a favorable tolerability profile with no serious adverse effects documented.[Evidence: A][3]
For nicotinamide (a related NAD+ precursor), regular clinical monitoring is not indicated at doses below 1500 mg/day.[Evidence: D][9] Adverse effects from niacin/nicotinamide are dose-dependent and typically improve with dose reduction.[Evidence: D][9]
Important: These dosages represent what has been studied in clinical trials. Individual supplementation decisions should be made in consultation with a healthcare provider.
⚠️ Risks, Side Effects, and Warnings
Side Effects from Clinical Studies
A systematic review evaluating NADH supplementation safety found it to be safe with a low incidence of adverse effects.[Evidence: A][1] Documented adverse effects include muscle pain, nervous disorders, fatigue, sleep disturbance, and headaches.[Evidence: A][1]
For NMN specifically, a systematic review of 10 RCTs with 437 patients found no serious adverse effects documented and described a favorable tolerability profile.[Evidence: A][3]
Niacin vs. Nicotinamide Safety
An umbrella review of 14 prior reviews examined adverse effects of oral niacin and nicotinamide. Both compounds can cause gastrointestinal upset, liver dysfunction, flushing, skin rash, and fatigue.[Evidence: D][9]
Importantly, nicotinamide is safer than niacin.[Evidence: D][9] Adverse effects are dose-dependent and typically improve with dose reduction.[Evidence: D][9]
Long-Term Considerations
A benefit/risk analysis reviewing 1545 articles (147 included: 113 preclinical, 34 clinical) identified limited acute toxicity but noted that long-term human trials remain limited.[Evidence: D][8]
Potential risks identified from mechanistic research include toxic metabolite accumulation, cancer promotion, and cellular senescence.[Evidence: D][8] These are theoretical concerns that require further investigation in long-term human studies.
Special Populations
Pregnancy and Lactation: No safety data is available for NAD+ precursor supplementation during pregnancy or lactation. Consultation with a healthcare provider is essential.
Pediatric Use: No safety data for pediatric populations. Not recommended without medical supervision.
Older Adults: NMN and NR have demonstrated safety in older adult populations in clinical studies.[Evidence: B][7][Evidence: A][3]
🥗 Practical Recommendations for NAD+ Testing
Who May Benefit from NAD+ Testing
- NAD+ supplement users: Testing before starting supplementation establishes a baseline, and follow-up testing (typically 6-12 weeks later) can assess response. The NR study demonstrated measurable NAD+ increases after 6 weeks of supplementation.[Evidence: B][7]
- Longevity-focused individuals: Since NAD+ declines with aging and affects all hallmarks of the aging process,[Evidence: D][5] testing may help track this biomarker as part of a broader health optimization strategy.
- Those with age-related concerns: NAD+ precursors have shown favorable outcomes in age-related disorders based on systematic reviews.[Evidence: D][8]
What to Know Before Testing
Sample Type: LC-MS/MS testing can be performed on blood, plasma, cells, platelets, CSF, or urine samples.[Evidence: D][4] The specific sample type depends on the testing laboratory's methodology.
Sample Handling: NAD+ measurement faces sample instability challenges—modern methods address this, but following the laboratory's collection and shipping instructions precisely is important.[Evidence: D][4]
Reference Ranges: Standardized clinical reference ranges for NAD+ levels are still being established in the field. Results should be interpreted with guidance from healthcare providers familiar with longevity medicine.
If Considering NAD+ Precursor Supplementation
Three primary NAD+ precursors are available: nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and nicotinamide riboside hydride (NRH).[Evidence: A][6]
Research evidence supports that these precursors can elevate blood NAD+ levels.[Evidence: A][2] Animal studies show NAD+ repletion extends healthspan and lifespan, with therapeutic potential for aging, metabolic, and neurodegenerative diseases.[Evidence: A][6]
Timing for Retesting: Based on the available research, retesting 6-8 weeks after starting supplementation is reasonable, as the RCT with NR showed effects at 6 weeks.[Evidence: B][7]
⚖️ NAD+ Testing Sample Types Comparison
LC-MS/MS methodology for NAD+ metabolite quantification is applicable to multiple biological sample types.[Evidence: D][4] Each sample type offers different information about NAD+ status:
| Sample Type | What It Measures | Clinical Applications |
|---|---|---|
| Blood/Plasma | Circulating NAD+ and metabolites | General NAD+ status assessment; most common sample type |
| Cells/Platelets | Intracellular NAD+ levels | Cellular NAD+ status; may better reflect tissue levels |
| Cerebrospinal Fluid | CNS NAD+ metabolites | Neurological research applications |
| Urine | NAD+ metabolite excretion | Non-invasive; reflects metabolite turnover |
Note: The methodology paper describes LC-MS/MS as applicable to these various sample types.[Evidence: D][4] Availability of specific sample types depends on the testing provider. Most consumer testing services use blood samples.
Intracellular vs. Plasma Measurement
An important consideration in NAD+ testing is whether the measurement reflects intracellular NAD+ (inside cells) or plasma NAD+ (in blood fluid). The NR study demonstrated that supplementation increased NAD+ specifically in neuronal extracellular vesicles, providing insight into how NAD+ precursors affect different compartments.[Evidence: B][7]
NAD+ metabolites influence cellular metabolism, inflammation, and oxidative stress.[Evidence: D][4] The specific measurement approach can provide different insights depending on the clinical question.
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- NAD+ precursor supplementation (NMN, NR) reliably elevates blood NAD+ levels based on a meta-analysis of 12 RCTs with 513 participants[Evidence: A][2]
- Oral nicotinamide riboside at 500 mg twice daily for 6 weeks increased NAD+ in neuronal extracellular vesicles and decreased neurodegenerative biomarkers (Aβ42, pJNK, pERK1/2) in healthy older adults[Evidence: B][7]
- NADH supplementation demonstrates low adverse effect incidence with benefits including improved anxiety symptoms, reduced heart rate stress response, and enhanced muscle insulin sensitivity[Evidence: A][1]
- NAD+ is fundamental for energy metabolism, cell signaling, and mitochondrial homeostasis, with three primary precursors (NR, NMN, NRH) showing therapeutic potential[Evidence: A][6]
- LC-MS/MS methodology provides validated quantification of NAD+ metabolites across multiple biological sample types[Evidence: D][4]
What's NOT Yet Proven
- Clinical outcomes gap: Despite NAD+ elevation, a meta-analysis found "most clinically relevant outcomes were not significantly different between NMN supplementation and control group"[Evidence: A][2]
- Physical performance: A systematic review of 10 RCTs found only modest grip strength and skeletal mass improvements that were not statistically significant[Evidence: A][3]
- Optimal reference ranges: Standardized clinical reference ranges for NAD+ levels have not been established
- Long-term outcomes: Studies are limited to 6-12 weeks; long-term human trial data beyond this period is limited[Evidence: D][8]
- Special populations: No safety data for pregnancy, lactation, or pediatric use
Where Caution Is Needed
- Potential long-term risks identified in mechanistic research include toxic metabolite accumulation, cancer promotion, and cellular senescence—though these are theoretical concerns requiring further human studies[Evidence: D][8]
- Niacin and nicotinamide can cause GI upset, liver dysfunction, flushing, skin rash, and fatigue; nicotinamide is safer than niacin but effects are dose-dependent[Evidence: D][9]
- Quality concerns identified: A meta-analysis noted quality concerns in 7 of the included studies and potential overstatement of benefits in the literature[Evidence: A][2]
- Sample instability challenges exist in NAD+ measurement—proper sample handling is critical for accurate results[Evidence: D][4]
Should YOU Try NAD+ Testing?
Best suited for: Individuals interested in tracking NAD+ precursor supplementation response; those working with longevity medicine practitioners; people who want to establish baseline biomarkers before interventions.
Not recommended for: Those seeking diagnosis of specific medical conditions (NAD+ testing is not a diagnostic test for disease); individuals expecting definitive "optimal" reference ranges (these are still being established); pregnant or breastfeeding women without medical supervision.
Realistic timeline: Research shows NAD+ elevation can be measured within 6 weeks of supplementation.[Evidence: B][7] Baseline testing before starting interventions, followed by retesting at 6-8 weeks, provides measurable data points.
When to consult a professional: Before starting any supplementation regimen; when interpreting test results; if experiencing adverse effects; if you have underlying health conditions or take medications.
Frequently Asked Questions
What are the symptoms of low NAD+ levels?
NAD+ is involved in metabolism, energy production, DNA repair, mitophagy, and autophagy, and influences inflammation and neuronal signaling. While specific symptoms of 'low NAD+' are not clearly defined in clinical literature, NAD+ declines with aging and affects all hallmarks of the aging process.[Evidence: D][5] General symptoms associated with cellular energy decline may include fatigue, cognitive changes, and reduced physical performance. However, these symptoms are non-specific and can have many causes. Testing is the only way to assess actual NAD+ levels.
Is intracellular NAD+ testing better than blood plasma testing?
Both intracellular and plasma NAD+ measurements provide useful information, but they assess different compartments. LC-MS/MS methodology can quantify NAD+ in blood, plasma, cells, and platelets. Research has specifically examined NAD+ in neuronal extracellular vesicles as a potential monitoring tool for brain NAD+ response to supplementation. The 'better' test depends on the clinical question—intracellular measurement may better reflect tissue NAD+ status, while plasma is more accessible.
Does insurance typically cover NAD+ testing?
NAD+ testing is generally considered a wellness or functional medicine test rather than a standard diagnostic test. Coverage varies by insurance plan and region. Most individuals pay out-of-pocket, though Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) may qualify for reimbursement in some cases. Contact your specific insurance provider for coverage details.
How long does it take for NAD+ supplementation to show effects on testing?
Based on available research, measurable changes in NAD+ levels can occur within 6 weeks. An RCT with 22 healthy older adults demonstrated that oral nicotinamide riboside at 500 mg twice daily for 6 weeks increased NAD+ in neuronal extracellular vesicles. Longer trials (9-12 weeks) have been used to assess functional outcomes like physical performance. Retesting 6-8 weeks after starting supplementation is a reasonable timeframe based on this evidence.
Is NAD+ a reliable biomarker for biological aging?
NAD+ has emerged as a biomarker of interest in aging research. NAD+ declines with aging, affecting all hallmarks of the aging process. Preclinical evidence supports NAD+ precursors for Alzheimer's and Parkinson's disease. Multiple human clinical trials are currently underway to further establish NAD+'s role as a longevity biomarker. While promising, standardized interpretation of NAD+ levels as an aging biomarker continues to be developed.
What is the difference between testing NAD+ vs. NADH?
NAD+ and NADH are two forms of the same molecule—NAD+ is the oxidized form and NADH is the reduced form. Together, they maintain cellular redox balance through electron transport, serving as coenzymes in glycolysis and oxidative phosphorylation. LC-MS/MS methodology can measure both NAD+ and its metabolites as part of the 'NADome' assessment. The NAD+/NADH ratio provides information about cellular redox status and metabolic health.
Why test NAD+ levels before starting supplementation?
Testing before supplementation establishes a baseline NAD+ level, allowing you to objectively measure whether your intervention is working. A meta-analysis confirmed that NMN supplementation elevates blood NAD+ levels, but individual responses may vary. Baseline testing also helps identify if you have suboptimal NAD+ levels that might benefit from intervention, rather than supplementing blindly. Follow-up testing after 6-12 weeks can confirm whether levels have improved.
Are the clinical benefits of raising NAD+ levels established?
Research shows NAD+ precursor supplementation does elevate blood NAD+ levels. However, a meta-analysis of 12 RCTs noted that 'most clinically relevant outcomes were not significantly different between NMN supplementation and control group' despite NAD+ elevation. NADH supplementation has shown improved anxiety symptoms, reduced heart rate stress response, and enhanced muscle insulin sensitivity in a systematic review. The gap between NAD+ elevation and clinical benefits requires ongoing research.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Gindri IM, Ferrari G, Pinto LPS, et al. American Journal of Physiology: Endocrinology and Metabolism, 2024; 326(4):E417-E427. PubMed | DOI [Evidence: A]
- 2 . Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Zhang J, Poon ET, Wong SH. Critical Reviews in Food Science and Nutrition, 2025; 65(22):4382-4400. PubMed | DOI [Evidence: A]
- 3 . Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials. Wen J, Syed B, Kim S, et al. Cureus, 2024; 16(8):e65961. PubMed | DOI [Evidence: A]
- 4 . Clinical Assessment of the NADome as Biomarkers for Healthy Aging. Jayasena T, Bustamante S, Clement J, et al. Methods in Molecular Biology, 2020; 2138:207-216. PubMed | DOI [Evidence: D]
- 5 . Roles of NAD+ in Health and Aging. Lautrup S, Hou Y, Fang EF, Bohr VA. Cold Spring Harbor Perspectives in Medicine, 2024; 14(1):a041193. PubMed | DOI [Evidence: D]
- 6 . Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF. Mechanisms of Ageing and Development, 2021; 199:111567. PubMed | DOI [Evidence: A]
- 7 . Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin. Vreones M, Mustapic M, Moaddel R, et al. Aging Cell, 2023; 22(1):e13754. PubMed | DOI [Evidence: B]
- 8 . NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Braidy N, Liu Y. Experimental Gerontology, 2020; 132:110831. PubMed | DOI [Evidence: D]
- 9 . The adverse effects of oral niacin/nicotinamide - an overview of reviews. Young SL, Gazzard G. Eye, 2025; 39(16):2852-2859. PubMed | DOI [Evidence: D]
- 10 . Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders. Schiuma G, Lara D, Clement J, Narducci M, Rizzo R. Antioxidants & Redox Signaling, 2024. PubMed | DOI [Evidence: D]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
